R SCOTT GREER Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for R SCOTT GREER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of R SCOTT GREER. R SCOTT GREER is Director in STEMCELLS INC ($STEM) and Director in NEKTAR THERAPEUTICS ($NKTR) and Director in Inogen Inc ($INGN) and Director in Auspex Pharmaceuticals, Inc. ($ASPX) and Director in Versartis, Inc. ($VSAR) and Director in Sientra, Inc. ($SIEN).
Latest Insider Trading Transactions of R SCOTT GREER
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARAV, ASPX, INGN, MBOT, NKTR, SIEN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 12 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Grant | A | 0.00 | 2,754 | 0 | 30,775 | 28 K to 30.8 K (+9.83 %) |
| Feb 04 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | M | 44.19 | 10,000 | 441,900 | 0 | |
| Feb 04 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | M | 43.21 | 3,334 | 144,062 | 0 | |
| Feb 04 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | M | 46.66 | 6,666 | 311,036 | 0 | |
| Feb 04 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Buy | M | 44.19 | 10,000 | 441,900 | 28,021 | 18 K to 28 K (+55.49 %) |
| Feb 04 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Buy | M | 43.21 | 3,334 | 144,062 | 18,021 | 14.7 K to 18 K (+22.70 %) |
| Feb 04 2021 | INGN | Inogen Inc | GREER R SCOTT | Director | Buy | M | 46.66 | 6,666 | 311,036 | 14,687 | 8 K to 14.7 K (+83.11 %) |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 18.91 | 18,200 | 344,162 | 18,200 | |
| Sep 24 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 9,100 | 0 | 185,674 | 176.6 K to 185.7 K (+5.15 %) |
| Jul 10 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 9.24 | 40,000 | 369,600 | 0 | |
| Jul 10 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 25.00 | 15,009 | 375,225 | 176,574 | 191.6 K to 176.6 K (-7.83 %) |
| Jul 10 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 9.24 | 40,000 | 369,600 | 191,583 | 151.6 K to 191.6 K (+26.39 %) |
| Jul 10 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 9.24 | 40,000 | 369,600 | 0 | |
| Jul 10 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 25.00 | 15,009 | 375,225 | 176,574 | 191.6 K to 176.6 K (-7.83 %) |
| Jul 10 2020 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 9.24 | 40,000 | 369,600 | 191,583 | 151.6 K to 191.6 K (+26.39 %) |
| May 12 2020 | INGN | Inogen Inc | GREER R SCOTT | Director | Grant | A | 0.00 | 4,540 | 0 | 8,021 | 3.5 K to 8 K (+130.42 %) |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 18.80 | 13,000 | 244,400 | 13,000 | |
| Sep 27 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 6,500 | 0 | 151,583 | 145.1 K to 151.6 K (+4.48 %) |
| May 10 2019 | INGN | Inogen Inc | GREER R SCOTT | Director | Grant | A | 0.00 | 2,474 | 0 | 3,463 | 989 to 3.5 K (+250.15 %) |
| Mar 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 5.14 | 10,000 | 51,400 | 0 | |
| Mar 12 2019 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 5.14 | 10,000 | 51,400 | 145,083 | 135.1 K to 145.1 K (+7.40 %) |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 60.91 | 9,500 | 578,645 | 9,500 | |
| Oct 01 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 4,750 | 0 | 135,083 | 130.3 K to 135.1 K (+3.64 %) |
| Sep 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 5.14 | 10,000 | 51,400 | 10,000 | |
| Sep 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 67.39 | 10,000 | 673,900 | 130,333 | 140.3 K to 130.3 K (-7.13 %) |
| Sep 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 5.14 | 10,000 | 51,400 | 140,333 | 130.3 K to 140.3 K (+7.67 %) |
| Jun 07 2018 | SIEN | Sientra, Inc. | GREER R SCOTT | Director | Grant | A | 20.44 | 6,116 | 125,011 | 58,773 | 52.7 K to 58.8 K (+11.61 %) |
| Jun 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 5.14 | 8,600 | 44,204 | 20,000 | |
| Jun 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 5.14 | 1,400 | 7,196 | 28,600 | |
| Jun 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 60.00 | 8,600 | 516,000 | 130,333 | 138.9 K to 130.3 K (-6.19 %) |
| Jun 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 5.14 | 8,600 | 44,204 | 138,933 | 130.3 K to 138.9 K (+6.60 %) |
| Jun 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 61.99 | 1,400 | 86,786 | 130,333 | 131.7 K to 130.3 K (-1.06 %) |
| Jun 06 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 5.14 | 1,400 | 7,196 | 131,733 | 130.3 K to 131.7 K (+1.07 %) |
| May 14 2018 | INGN | Inogen Inc | GREER R SCOTT | Director | Grant | A | 0.00 | 989 | 0 | 989 | 0 to 989 |
| May 09 2018 | SIEN | Sientra, Inc. | GREER R SCOTT | Director | Buy | P | 13.50 | 11,111 | 149,999 | 52,657 | 41.5 K to 52.7 K (+26.74 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 14.26 | 30,000 | 427,800 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 14.26 | 30,000 | 427,800 | 0 | |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 92.22 | 30,000 | 2,766,600 | 130,333 | 160.3 K to 130.3 K (-18.71 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Sell | S | 92.22 | 30,000 | 2,766,600 | 130,333 | 160.3 K to 130.3 K (-18.71 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 14.26 | 30,000 | 427,800 | 160,333 | 130.3 K to 160.3 K (+23.02 %) |
| Apr 09 2018 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 14.26 | 30,000 | 427,800 | 160,333 | 130.3 K to 160.3 K (+23.02 %) |
| Dec 22 2017 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Grant | A | 0.00 | 11,200 | 0 | 44,380 | 33.2 K to 44.4 K (+33.76 %) |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 21.75 | 22,500 | 489,375 | 22,500 | |
| Sep 21 2017 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 9,000 | 0 | 130,333 | 121.3 K to 130.3 K (+7.42 %) |
| Jun 26 2017 | SIEN | Sientra, Inc. | GREER R SCOTT | Director | Grant | A | 9.72 | 12,861 | 125,009 | 41,546 | 28.7 K to 41.5 K (+44.84 %) |
| Jun 06 2017 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Option Exercise | A | 15.83 | 6,850 | 108,401 | 6,850 | |
| Jun 06 2017 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Grant | A | 0.00 | 3,480 | 0 | 33,180 | 29.7 K to 33.2 K (+11.72 %) |
| May 12 2017 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | A | 83.30 | 10,000 | 833,000 | 10,000 | |
| Oct 25 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | P | 13.50 | 15,000 | 202,500 | 121,333 | 106.3 K to 121.3 K (+14.11 %) |
| Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 19.15 | 20,000 | 383,000 | 20,000 | |
| Sep 23 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Grant | A | 0.00 | 8,000 | 0 | 106,333 | 98.3 K to 106.3 K (+8.14 %) |
| Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 0.00 | 15,000 | 0 | 0 | |
| Sep 19 2016 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 0.00 | 15,000 | 0 | 98,333 | 83.3 K to 98.3 K (+18.00 %) |
| Jun 27 2016 | SIEN | Sientra, Inc. | GREER R SCOTT | Director | Grant | A | 6.69 | 18,685 | 125,003 | 28,685 | 10 K to 28.7 K (+186.85 %) |
| May 20 2016 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Option Exercise | A | 8.12 | 14,625 | 118,755 | 14,625 | |
| May 20 2016 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Grant | A | 0.00 | 4,625 | 0 | 29,700 | 25.1 K to 29.7 K (+18.44 %) |
| May 13 2016 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | A | 44.19 | 10,000 | 441,900 | 10,000 | |
| Jan 05 2016 | STEM | STEMCELLS INC | GREER R SCOTT | Director | Grant | A | 0.00 | 146,342 | 0 | 290,183 | 143.8 K to 290.2 K (+101.74 %) |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 266 | 80 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 1,517 | 455 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 496 | 149 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 688 | 206 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 1,783 | 535 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 9,280 | 2,784 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | X | 0.30 | 1,188 | 356 | 0 | |
| Nov 20 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Buy | X | 0.30 | 15,218 | 4,565 | 15,218 | 0 to 15.2 K |
| Nov 13 2015 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Buy | P | 10.17 | 9,500 | 96,615 | 25,075 | 15.6 K to 25.1 K (+61.00 %) |
| Nov 13 2015 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Buy | P | 10.16 | 200 | 2,032 | 15,575 | 15.4 K to 15.6 K (+1.30 %) |
| Nov 13 2015 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Buy | P | 10.15 | 300 | 3,045 | 15,375 | 15.1 K to 15.4 K (+1.99 %) |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 11.34 | 10,000 | 113,400 | 0 | |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | M | 11.34 | 22,500 | 255,150 | 0 | |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 11.34 | 10,000 | 113,400 | 83,333 | 73.3 K to 83.3 K (+13.64 %) |
| Oct 19 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Buy | M | 11.34 | 22,500 | 255,150 | 73,333 | 50.8 K to 73.3 K (+44.26 %) |
| Oct 15 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | A | 43.21 | 3,334 | 144,062 | 3,334 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 15,000 | |
| Sep 17 2015 | NKTR | NEKTAR THERAPEUTIC ... | GREER R SCOTT | Director | Option Exercise | A | 12.80 | 12,500 | 160,000 | 12,500 | |
| Aug 26 2015 | INGN | Inogen Inc | GREER R SCOTT | Director | Option Exercise | A | 46.66 | 6,666 | 311,036 | 6,666 | |
| Aug 18 2015 | SIEN | Sientra, Inc. | GREER R SCOTT | Director | Option Exercise | A | 25.18 | 7,037 | 177,192 | 16,127 | |
| Jul 01 2015 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Option Exercise | A | 14.73 | 13,100 | 192,963 | 13,100 | |
| Jul 01 2015 | VSAR | Versartis, Inc. | GREER R SCOTT | Director | Grant | A | 0.00 | 4,575 | 0 | 15,075 | 10.5 K to 15.1 K (+43.57 %) |
| May 06 2015 | ASPX | Auspex Pharmaceuti ... | GREER R SCOTT | Director | Option Exercise | D | 18.13 | 20,000 | 362,600 | 0 | |
| May 06 2015 | ASPX | Auspex Pharmaceuti ... | GREER R SCOTT | Director | Sell | U | 0.00 | 7,190 | 0 | 0 | 7.2 K to 0 (-100.00 %) |
Page: 1